Wisp, the largest women’s telehealth company in the U.S., today announced its expansion into clinician-guided longevity care with the launch of its new Longevity and Healthy Aging category. The ...

BARK's latest analyst update keeps the fair value price target steady at US$2.00, signaling no change in what the models say the shares are worth today. The tweaks behind that headline figure largely ...

Waking up overheated at 3am? The new Eight Sleep Pod 5 introduces a rapid cooling feature designed to tackle night sweats and improve sleep ...

If you’re a Whoop member, you can expect to see two new women’s health updates for both hormonal insights and blood panels. Anna Gragert (she/her/hers) was previously the lifestyle editor at ...

FAYETTEVILLE, GA, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Spinal cord injury often triggers a cascade of ...

These initiatives reflect the company's commitment to advancing women's health in an area that has historically been under-researched and underrepresented in data, clinical standards, and performance ...

These initiatives reflect the company's commitment to advancing women's health in an area that has historically been under-researched and underrepresented in data, clinical standards, and performance ...

As the hair-loss market surges, young women are facing rising costs, risky treatments, and mounting pressure to fix a problem ...

The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors through allosteric signaling. (Nanowerk News) A research team has developed an ...

Whoop has announced a new biomarker panel specifically for women that broadens the scope of its Advanced Labs blood test analysis, as well as an updated suite of dynamic cycle insights. Launching in ...

Figure 1. Conceptual visualization of additive manufacturing-enabled IVF workflows used in advanced embryo screening. Anthony Palumbo and Charles Goulding examine how additive manufacturing is ...

Saying RED-S doesn’t exist may sound like blasphemy to some and clickbait to others, but it’s a captivating title — and the focus of a recent 2024 paper. If that question has you thinking, “Of course ...